A 5-HT2C receptor agonist for the treatment of obesity?

被引：0
|
作者：
Van Baak, M
Lentjes, M
Mujakovic, S
Slaap, B
Saris, W
机构：
来源：
OBESITY RESEARCH | 2003年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A110 / A111
页数：2
相关论文
共 50 条
  • [21] Epilepsy and obesity in serotonin 5-HT2C receptor mutant mice
    Heisler, LK
    Chu, HM
    Tecott, LH
    ADVANCES IN SEROTONIN RECEPTOR RESEARCH: MOLECULAR BIOLOGY, SIGNAL TRANSDUCTION, AND THERAPEUTICS, 1998, 861 : 74 - 78
  • [22] Dynamic 5-HT2C Receptor Editing in a Mouse Model of Obesity
    Schellekens, Harriet
    Clarke, Gerard
    Jeffery, Ian B.
    Dinan, Timothy G.
    Cryan, John F.
    PLOS ONE, 2012, 7 (03):
  • [23] Deramciclane, a putative anxiolytic drug, is a serotonin 5-HT2C receptor inverse agonist but fails to induce 5-HT2C receptor down-regulation
    E.-P. Pälvimäki
    Hannu Majasuo
    Mikko Kuoppamäki
    Pekka T. Männistö
    Erkka Syvälahti
    Jarmo Hietala
    Psychopharmacology, 1998, 136 : 99 - 104
  • [24] Deramciclane, a putative anxiolytic drug, is a serotonin 5-HT2C receptor inverse agonist but fails to induce 5-HT2C receptor down-regulation
    Pälvimäki, EP
    Majasuo, H
    Kuoppamäki, M
    Männistö, PT
    Syvälahti, E
    Hietala, J
    PSYCHOPHARMACOLOGY, 1998, 136 (02) : 99 - 104
  • [25] Agonist diversity in 5-HT2C receptor-mediated weight control
    Hayashi, A.
    Suzuki, M.
    Sasamata, M.
    Miyata, K.
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 101 : 15 - 15
  • [26] Lorcaserin: A novel, selective 5-HT2C-receptor agonist for the treatment of obesity
    Pauli, Maribeth
    Abdelghany, Sam
    FORMULARY, 2010, 45 (06) : 180 - 186
  • [27] Preclinical evidence for combining the 5-HT2C receptor agonist lorcaserin and varenicline as a treatment for nicotine dependence
    Fletcher, Paul J.
    Li, Zhaoxia
    Silenieks, Leo B.
    MacMillan, Cam
    DeLannoy, Ines
    Higgins, Guy A.
    ADDICTION BIOLOGY, 2019, 24 (03) : 376 - 387
  • [28] Discovery, SAR and biology of 5-HT2C receptors for the treatment of obesity
    Smith, BM
    Smith, J
    Tsai, JH
    Schultz, JA
    Gilson, C
    Chen, R
    Estrada, S
    Park, D
    Prieto, E
    Sengupta, D
    Saldana, H
    Thomsen, W
    Kevin, W
    Creehan, K
    Gonzalez, L
    Menzaghi, F
    Bjenning, C
    Beeley, N
    Webb, RR
    Behan, D
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U159 - U159
  • [29] Targeting the 5-HT2C Receptor in Biological Context and the Current State of 5-HT2C Receptor Ligand Development
    Wold, Eric A.
    Wild, Christopher T.
    Cunningham, Kathryn A.
    Zhou, Jia
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2019, 19 (16) : 1381 - 1398
  • [30] 5-HT2C receptor and leptin polymorphisms, obesity and metabolic syndrome in schizophrenia
    Yevtushenko, Olga
    Cooper, Stephen
    O'Neill, Ryan
    Doherty, Jeniffer
    Reynolds, Gavin
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2006, 141B (07) : 789 - 789
12345